Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Multiple Sclerosis News

Sheffield Hallam University Seeks Early Diagnosis For MS

Main Category: Multiple Sclerosis
Article Date: 11 Dec 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 and a half stars

4.5 (2 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Sheffield Hallam University has begun a new three-year study which it hopes will lead to a test for early diagnosis of multiple sclerosis (MS). Early diagnosis means treatment can be started sooner, helping people with MS to remain active for longer.

Lead by Professor Nicola Woodroofe, head of The Biomedical Research Centre (BMRC) at the University, the project will seek to determine whether specific modifications to amino acids in specific brain proteins may ultimately be responsible for the body's own immune system attacking proteins found exclusively in the central nervous system. The grant of £105,000 will fund a full time PhD student over three years and associated research costs.

"This study will further research the causes and crucial early stages of multiple sclerosis," said Professor Woodroofe. "Previous studies carried out have recently provided evidence changed proteins may be found in people with MS - a vital clue to understanding causes of the disease."

Using post mortem tissue samples from the UK MS Society Tissue Bank, MS patients and healthy controls, the BMRC will measure: the levels of PAD enzymes (which produce the amino acid changes), the changed proteins themselves and the antibodies developed by patients. Analysing the results obtained and their relationship to symptoms, they hope to find an antibody specific to people with MS.

The grant is one of a number of major awards to be given to Sheffield Hallam by the MS Society in recent weeks. Ed Holloway from the MS Society, said: "We hope this project will contribute not only to our understanding of MS, but to our ability to diagnose and combat the disease. MS is a challenging affliction and the research undertaken by Sheffield Hallam is a key step in our ongoing efforts to help sufferers.

"We have chosen the University thanks to its superb research track record and the excellent working relationship which we have developed with them."

Sheffield Hallam University




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Hydrangea Root Shows Promise In Treating Autoimmune Disorders
05 Jun 2009
US researchers found that a drug made from the root of the hydrangea plant, which has for centuries been used in Chinese medicine, showed promising results in treating autoimmune disorders such as rheumatoid arthritis...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

An MS Drug Back on the Market image An MS Drug Back on the Market

After being suspended from the market for safety reasons, natalizumab is again available for the treatment of multiple sclerosis. Safeguards are in place because of a small risk in developing a serious brain infection. Should you consider taking this drug...

View more videos...